 Connection
Diana Medgyesy to Colorectal Neoplasms
This is a "connection" page, showing publications Diana Medgyesy has written about Colorectal Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.085 |
|
|
|
-
Royce ME, Medgyesy D, Zukowski TH, Dwivedy S, Hoff PM, Pazdur R. Colorectal cancer: chemotherapy treatment overview. Oncology (Williston Park). 2000 Dec; 14(12 Suppl 14):40-6.
Score: 0.023
-
Hoff PM, Royce M, Medgyesy D, Brito R, Pazdur R. Oral fluoropoyrimidines. Semin Oncol. 1999 Dec; 26(6):640-6.
Score: 0.022
-
Brito RA, Medgyesy D, Zukowski TH, Royce ME, Ravandi-Kashani F, Hoff PM, Pazdur R. Fluoropyrimidines: a critical evaluation. Oncology. 1999 Jul; 57 Suppl 1:2-8.
Score: 0.021
-
Pazdur R, Medgyesy DC, Winn RJ, Dakhil SR, Moore DF, Scalzo A, Hoff PM, Arbuck SG, Abbruzzese JL. Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma. Invest New Drugs. 1998-1999; 16(4):341-6.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|